Literature DB >> 578654

Simultaneous determination of furosemide and two of its possible metabolites in biological fluids.

E Mikkelsen, F Andreasen.   

Abstract

By the means of thin-layer chromatography (TLC) prior to fluorometry it was possible to determine furosemide (F) in plasma and urine with improved specificity. Antranilic acid (A) and 4-chlor-5-sulphamoyl-antranilic acid (CSA) could be determined simultaneously with F in plasma. In urine, only F and A could be determined quantitatively by this method. The sensitivity is 0.1 microgram/ml for F and 0.15-0.20 microgram/ml for A and CSA. By means of TLC prior to fluorometry the blank value for F was reduced in normal subjects and in different groups of patients, and its diurnal variation was eliminated. The average values of the plasma concentrations of F after the intravenous injection of 40 mg into 12 normal subjects were at all times found to be lower by the TLC method than by the fluorometric method without TLC. A higher plasma clearance and a lower volume of distribution were found for F when the values obtained by the TLC method were used for the calculation.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 578654     DOI: 10.1111/j.1600-0773.1977.tb02146.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN: 0001-6683


  8 in total

Review 1.  Furosemide (frusemide). A pharmacokinetic/pharmacodynamic review (Part II).

Authors:  L L Ponto; R D Schoenwald
Journal:  Clin Pharmacokinet       Date:  1990-06       Impact factor: 6.447

Review 2.  Clinical pharmacokinetics of frusemide.

Authors:  R E Cutler; A D Blair
Journal:  Clin Pharmacokinet       Date:  1979 Jul-Aug       Impact factor: 6.447

3.  Distribution, elimination and natriuretic effect of furosemide in patients with severe arterial hypertension.

Authors:  F Andreasen; O L Pedersen; E Mikkelsen
Journal:  Eur J Clin Pharmacol       Date:  1978-12-01       Impact factor: 2.953

4.  Effect of probenecid on excretion and natriuretic action of furosemide.

Authors:  F Andreasen; B Sigurd; E Steiness
Journal:  Eur J Clin Pharmacol       Date:  1980-11       Impact factor: 2.953

5.  Pharmacokinetics of furosemide in anephric patients and in normal subjects.

Authors:  F Andreasen; H E Hansen; E Mikkelsen
Journal:  Eur J Clin Pharmacol       Date:  1978-03-17       Impact factor: 2.953

Review 6.  Clinical pharmacokinetics of diuretics.

Authors:  B Beermann; M Groschinsky-Grind
Journal:  Clin Pharmacokinet       Date:  1980 May-Jun       Impact factor: 6.447

7.  Pharmacokinetics/pharmacodynamics of furosemide in man: a review.

Authors:  L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1979-02

8.  Kinetics of furosemide in children with chronic renal failure undergoing regular haemodialysis.

Authors:  E Riva; E Fossali; A Bettinelli
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.